Awareness and attitude of the public toward personalized medicine in Korea
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- PLOS ONE13(2) · 2018
- 피인용
- Web of Science 23Scopus 23
- FWCI (Scopus)
- 0.74
- JCR IF
- JCR 2017 2.766
- ISSN
- 1932-6203
저자
- Lee, Iyn-Hyang제1저자College of Pharmacy, Yeungnam University, Gyeongbuk-do, South Korea
- Kang, Hye-YoungCollege of Pharmacy, Yonsei University, Inchon, South Korea
- 서혜선College of Pharmacy, Pusan National University, Busan, South Korea
- Lee, SukhyangCollege of Pharmacy, Ajou University, Kyeonggi-do, South Korea
- Oh, Eun SilDepartment of Pharmaceutical Medicine and Regulatory Sciences, Colleges of Medicine and Pharmacy, Yonsei University, Incheon, South Korea
- Jeong, Hotcherl교신저자College of Pharmacy, Ewha Womans University, Seoul, South Korea
초록
Objectives As personalized medicine (PM) is expected to greatly improve health outcomes, efforts have recently been made for its clinical implementation in Korea. We aimed to evaluate public awareness and attitude regarding PM. Methods We performed a self-administered questionnaire survey to 703 adults, who participated in the survey on a voluntary basis. The primary outcome measures included public knowledge, attitude, and acceptance of PM. We conducted multinomial multivariate logistic analysis for outcome variables with three response categories and performed multivariate logistic regression analyses for dichotomous outcome variables. Results Only 28% of participants had knowledge that genetic factors can contribute to inter-individual variations in drug response and the definition of PM (199 out of 702). Higher family income was correlated with greater knowledge concerning PM (OR = 3.76, p = 0.034). A majority of respondents preferred integrated pharmacogenomic testing over drug-specific testing and agreed to inclusion of pharmacogenomic testing in the national health examination (64% and 77%, respectively), but only 51% were willing to pay for it. Discussion Our results identify the urgent need for public education as well as the potential health disparities in access to PM. This study helps to frame policies for implementing PM in clinical practice.
키워드
KNOWLEDGEPHARMACOGENOMICSASSOCIATIONPOPULATIONGENETICSGENOMERISK
식별자
- Scopus EID
- 2-s2.0-85042224933
- WoS UID
- 000425369800021



로그인
연구물 목록으로